TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Conference

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)

Rhea-AI Summary

TELA Bio, Inc. (NASDAQ: TELA), a leader in soft-tissue reconstruction solutions, has announced its participation in the Canaccord Genuity 44th Annual Growth Conference. The company's management team is set to present on August 14th, 2024, at 10:30 am ET. This event provides an opportunity for TELA Bio to showcase its innovative medical technology and growth strategies to investors and industry professionals.

Interested parties can access both the live presentation and archived webcast through TELA Bio's investor relations website at ir.telabio.com. This participation underscores TELA Bio's commitment to engaging with the investment community and highlights its position in the rapidly evolving medical technology sector.

News Market Reaction 1 Alert

+2.22% News Effect

On the day this news was published, TELA gained 2.22%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

07/25/2024 - 04:05 PM

MALVERN, Pa., July 25, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in the Canaccord Genuity 44^th Annual Growth Conference.

TELA’s management is scheduled to present at the Canaccord Genuity 44^th Annual Growth Conference at 10:30 am ET on August 14^th, 2024. Interested parties can access the live and archived webcast at ir.telabio.com.

About TELA Bio, Inc.
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com.

Investor Contact
Greg Chodaczek
347-620-7010
ir@telabio.com

FAQ

When is TELA Bio presenting at the Canaccord Genuity 44th Annual Growth Conference?

TELA Bio is scheduled to present at the Canaccord Genuity 44th Annual Growth Conference on August 14th, 2024, at 10:30 am ET.

How can investors access TELA Bio's presentation at the Canaccord Genuity conference?

Investors can access both the live and archived webcast of TELA Bio's presentation through the company's investor relations website at ir.telabio.com.